Introduction
Early gastric cancer (EGC) is defined as that in which invasion is confined to either the mucosa or submucosa, " 2004 by International and Japanese Gastric Cancer Associations gery, Yokohama City Kowan Hospital. The depth of invasion and lymph node metastases were evaluated preoperatively by computed tomography (CT) scans, fiberscopic examinations, and upper gastrointestinal series, and finally assessed macroscopically during the operation (surgical findings) and microscopically after the resection (pathological findings). The macroscopic diagnosis of depth of invasion was made from such findings as changes in the serosal surface, indurations, or mobility in the gastric wall. The status of lymph nodes was judged from the size of nodes and consistency by palpation. Depth of invasion and the presence of lymph node metastases were assessed visually and by palpation just after the operation, based on the macroscopic investigation of the resected specimens, and the findings were recorded according to the General rules for gastric cancer study [1] . Of the 280 patients, 140 were diagnosed as having EGC during surgery (sT1), while the rest were diagnosed with advanced disease (sT2-T4). Of the former 140 patients, 136 patients (a group with D1 dissection [n ϭ 35) and a group with D2 lymph node dissection [n ϭ 101]), were further investigated for this study; the remaining 4 patients were excluded because they underwent partial resection of the stomach without systemic lymph node dissection. Limited D1 dissection was employed for patients with severe complications or those with small, clinically diagnosed mucosal tumors that were unlikely to have lymph node metastases.
The surgical diagnosis of EGC was evaluated by determining the sensitivity (true positive rate; i.e., the number of lesions surgically diagnosed and pathologically confirmed as EGC divided by the number of surgically diagnosed EGCs), the specificity (true negative), and the accuracy (the number of lesions whose surgical and pathological diagnoses were in accordance divided by the total number of lesions). The accuracy of the surgical diagnosis of lymph node metastases was evaluated similarly. The 2 method and unpaired Student's t-test were used for comparisons between two groups. Logistic regression was used for multivariate analyses.
Results

Surgical diagnosis of EGC
Comparisons of surgical and pathological diagnoses are shown in Table 1 . The sensitivity, specificity, and accuracy of the surgical diagnosis of EGC were 96.4% (135 of 140), 90.0% (126 of 140), and 93.2% (261 of 280), respectively. In five patients with a false-positive sT1, three tumors had invaded the proper muscle, without lymph node metastases (mp and pN0), and two had invaded the subserosa, one with metastases to the level 1 nodes (ss and pN1), and the other to the level 2 nodes (ss and pN2). Macroscopic type, histological type, and maximal diameter obtained before surgery were compared between patients with a true-positive (sT1pT1) diagnosis and those with a false-positive (sT1pT2-4) diagnosis (Table 2 ). Although there was no significant difference between the two groups, all five patients with a false-positive diagnosis had macroscopically depressed type tumors. By Cox's regression analysis, none of the above three factors were significant predictors for the diagnosis of tumor depth.
Surgical diagnosis of lymph node metastases in sT1
The 136 patients who were diagnosed as having EGC (sT1) underwent curative resection with D2 or D1 lymph node dissection, and 127 of these patients were diagnosed as having no lymph node metastasis during surgery (sN0), while the remaining 9 patients were diag- Table 3 . The sensitivity, specificity, and accuracy of the surgical diagnosis of lymph node metastases were 55.6% (5 of 9), 94.5% (120 of 127), and 91.9% (125 of 136), respectively. Table 4 shows the data for macroscopic type, histological type, and maximal diameter (all of which details were obtained before surgery) in patients with true-negative (sN0pN0) and false-negative (sN0pN1-3) diagnoses. Only histological type was significantly different between the two groups. By Cox's regression analysis, histological type was a significant predictor of a false-negative result (P ϭ 0.026; hazard ratio, 6.53). (Table 5) In the above analyses of the surgical diagnosis of EGC, it became clear that all patients with a false-positive diagnosis had macroscopically depressed-type tumors and that a tumor with undifferentiated histology was a significant predictor of underestimation. Excluding patients with these two factors of macroscopically depressed type and undifferentiated histology, we examined the clinical value of the surgical diagnosis of lymph node metastases. Twenty-eight patients were eligible for this analysis and were selected from the 136 patients who were diagnosed surgically as having EGC (sT1). Of the 28 patients, 25 were diagnosed as having sN0 and 3 as having sN1. The sensitivity, specificity, and accuracy for the diagnosis of lymph node metastases were 66.7% (2/3), 100% (25/25), and 96.4% (27/28). All patients diagnosed as having sT1sN0 with macroscopically elevated and histologically differentiated tumors had no lymph node metastases pathologically.
Analysis of data in selected patients
Discussion
According to the guidelines of the Japanese Gastric Cancer Association, the optimal lymph node dissection for gastric cancer should be determined based on the surgical diagnosis of the depth of invasion (sT) and the extent of lymph node metastases (sN) [18] . In EGC, for example, sT1sN0 should be treated by limited D1 ϩ alpha and D1 ϩ beta dissection ("D1 ϩ alpha" dissection includes perigastric nodes and no. 7 nodes for tumors located in the middle or upper third of the stomach, and no. 7 and no. 8a nodes for tumors located in the lower third of the stomach, while "D1 ϩ beta" dissection denotes no. 7, no. 8a, and no. 9 node dissection besides perigastric nodes); sT1sN1 should be treated by limited D1 ϩ beta or D2 dissection; and sT1sN2 should be treated by D2 dissection. To enable these decisions to be made, surgical diagnosis of the stage has to be accurate. However, the accuracy of pre-and intraoperative diagnosis of EGC and lymph node metastases has not been reported so far. The surgical diagnosis of early disease was documented to be highly accurate, with high sensitivity and specificity, in the present study. The surgical diagnosis of depth of tumor invasion was made intraoperatively not only by changes in the serosal surface but also by the mobility of the tumor on the muscle layer, in addition to the preoperative diagnosis made by endoscopy and upper gastrointestinal series. These diagnoses are highly dependent on the experience of surgeons. Of our patients diagnosed as having "early" disease or sT1, the diagnoses in five patients were found to be false-positive (sT1pT2-4). Although there were no significant differences in the pathological factors examined between the patients with a correct diagnosis (sT1pT1) and those with a false-positive one (sT1pT1-4), all macroscopically elevated and flat-type tumors were correctly diagnosed as pT1. However, two of the five patients with a false-positive diagnosis patients had lymph node metastases. Thus, we should be more cautious in determining the depth of invasion of depressedtype tumors.
Considering the intraoperative assessment of lymph node metastases, it is accepted that it is not safe to diagnose lymph node metastases by size and palpation. However, there is no accurate way to diagnoses lymph node status. The new method of sentinel node biopsy has not yet been shown to be conclusive. In some tertiary hospitals, the pathological status of the nodes is checked by the analysis of frozen sections when malignant involvement is highly suspected, especially in far advanced disease. However, this method has not been accepted as a community standard for early disease. In many general hospitals, lymph node status in EGC is evaluated by the size and consistency of the nodes. Our objective was, therefore, to re-assess the accuracy of the standard methods and to elucidate the subset of the population in whom these routine gross methods can be safely employed.
The incidence of lymph node metastasis in EGC has been reported to be less than 20% [8, 10] . The high specificity but low sensitivity in the surgical diagnosis of lymph node metastases in the present study indicates the difficulty of diagnosing the presence of lymph node metastases intraoperatively. Other authors have also demonstrated the low sensitivity of the surgical diagnosis of nodal involvement [19] [20] [21] [22] . Usually, lymph node metastases were evaluated by the size and consistency of the nodes during surgery. However, increased size does not necessarily indicate the presence of metastasis [23] . Also, it is very rare to find enlarged lymph nodes in patients with an early stage disease. In the present series, 35 patients underwent D1 dissection and the remaining patients had a D2 dissection. It is possible that patients who underwent limited dissection had tumors invading lymph nodes at N2 stations which were not dissected. Therefore, in this study, the parameters we used to assess surgical diagnosis may have led to slight underestimation of the sensitivity.
In employing limited surgery in patients with EGC, the major problems are the underestimation of the depth of tumor invasion and the extent of lymph node metastases, because some of these patients could be cured by radical D2 lymphadenectomy. In our study, there were seven patients whose nodal status was underestimated (N0pN1-3). To examine whether these patients could have been predicted, we analyzed the macroscopic type, histological type, and maximal diameter of tumors by univariate and multivariate analyses comparing those with sN0pN0 (correctly diagnosed) and those with sN0pN1-3 (underestimated). Of the three factors examined, histological type was found to be a significant factor. These data suggest that the correct diagnosis of nodal metastasis during surgery is more difficult in undifferentiated than in differentiated carcinomas.
When patients with tumors of macroscopically depressed type and undifferentiated histology were excluded from our analysis, we found that all patients with sN0 had no lymph node metastasis pathologically. Therefore, limited nodal dissection could be safely performed in these selected patients.
In conclusion, the customization of surgery for EGC has been advocated. The low incidence of nodal metastasis and high survival rate are the basis for this recommendation. Although the depth of tumor invasion can be correctly assessed surgically, the presence of nodal metastases is hard to detect. One practical solution to this problem may be to employ limited surgery for those patients with macroscopically elevated and histologically differentiated tumors.
